Abstract
Introduction
Low‐dose‐rate brachytherapy is performed for localized prostate cancer. We report the first case of a bladder stone encompassing the seed migrated into the bladder in a patient treated with low‐dose‐rate brachytherapy.
Case presentation
A man was diagnosed with prostate cancer and underwent low‐dose‐rate brachytherapy. After 2 months, dysuria occurred, and ultrasonography revealed a needle‐shaped high‐intensity protruding from the prostate into the bladder. Cystoscopy examination found a seed link connector. With the possibility of natural dissolution of the seed link, careful observation was chosen. However, 16 months later, hematuria occurred, and an X‐ray revealed a bladder stone encompassing the seed. Compared with the X‐ray right after seeding, the seed located near the right bladder neck had fallen. The seed was removed by transurethral bladder lithotripsy.
Conclusion
Seeds should be carefully located within the prostate, otherwise a bladder stone may be formed encompassing the seed.
Keywords: bladder stone, migration, seed
Abbreviations & Acronyms
- EBRT
external beam radiotherapy
- HDR‐B
high‐dose‐rate brachytherapy
- LDR‐B
low‐dose‐rate brachytherapy
Keynote message.
This is the first image that confirms that the seed link connector has strayed into the bladder. We were even able to see the site of seed shedding initially, but later a bladder stone encompassing the seed was formed. The appearance of dysuria or hematuria after LDR‐B should be closely examined with seed migration in mind.
Introduction
Prostate cancer is the most prevalent cancer in Japan and the second most prevalent in the world. 1 Radiotherapy, including EBRT, LDR‐B, and HDR‐B, is performed for localized prostate cancer according to the risk. 2 Radical prostatectomy frequently used surgical clips, and clips migrating into the bladder have been previously reported. 3 , 4 , 5 , 6 Here, we report the first case of a bladder stone encompassing the seed migrated into the bladder in a patient treated with LDR‐B.
Case presentation
A 71‐year‐old male patient was diagnosed with localized prostate cancer (cT1cN0M0, initial prostate‐specific antigen: 9.41 ng/mL, Gleason Score: 3 + 3 = 6, and low risk of D'Amico classification) and underwent LDR‐B with I‐125 seed after 6 months of combined androgen blockade. Dysuria occurred after 2 months. Ultrasonography revealed a needle‐shaped high‐intensity protrusion from the prostate into the bladder, and cystoscopy examination detected a seed link connector (Fig. 1a,b). With the possibility of natural dissolution of the seed link, careful observation without any surgical treatment was performed. However, 16 months later, hematuria occurred, and an X‐ray revealed a bladder stone encompassing the seed (Fig. 2a,b). Compared with the X‐ray right after seeding, it revealed the seed located near the right bladder neck had fallen (Fig. 2c,d). The seed was removed by transurethral bladder lithotripsy (Fig. 3a–d). The stone consists of calcium oxalate. Hematuria and dysuria have improved, with no prostate cancer recurrence or further seed migration into the bladder postoperatively.
Fig. 1.

(a) Ultrasonography revealed a needle‐shaped high‐intensity substance from the prostate into the bladder. (b) Cystoscopy revealed a similar substance in the neck of the bladder.
Fig. 2.

(a) CT at the appearance of hematuria (axial). (b) X‐ray, bladder stone encompassing the SEED. (c) X‐ray after seeding. (d) Compared with the X‐ray right after seeding the seed located near the right bladder neck had fallen.
Fig. 3.

(a) Bladder stone observed during surgery. (b) The seed is identified within the stone. (c) The seed was removed by transurethral bladder lithotripsy. (d) The removed seed was comparable to the size of the 18‐G needle.
Discussion
Seed shedding into the bladder and bladder stones nucleating them have been previously reported. 7 , 8 Furthermore, seed shedding has been reported to cause urethral stones. 9 These cases are thought to have gradually migrated into the bladder from the prostatic tissue over time and exposed in the bladder or urethra, and finally formed bladder or urethral stones several years later. In our case, the seed remained connected initially as a connected seed was used in our hospital, but later it migrated into the bladder after the connector melted, and finally formed a stone encompassing the seed (Fig. 4). Our case is the first report of a bladder stone formation caused by this peculiar mechanism.
Fig. 4.

Stone formed to encompass the seed of the link seed inserted into the prostate, and the connector broke and fell into the bladder over time, causing the stone to grow larger.
LDR‐B has diverse complications, including frequent urination, intermittency, urgent incontinence, and hematuria. 10 , 11 , 12 , 13 We have also experienced ischemic enterocolitis after LDR‐B, and defecation as well as urination control is important. 14 Dysuria and hematuria in LDR‐B are reported in 7%–13% and 0%–14% of cases, respectively. 13 Furthermore, within the first postoperative years, dysuria often occurs within 1–2 months, and hematuria is relatively rare, occurring in 0.2% of cases. 10 In our case, symptoms appeared after 2 months, thus the disease was detected same time as the report. 7 , 8 , 9
Seeds dropout into the urethra has been reported in 29.7% of patients and 0.58% of the total sources, and the time of dropout is mostly within 7 days after LDR‐B. Technical problems induce dropout and seed migration. 10 , 11 , 13 Seed migration into the body is relatively common, occurring in 25%–55% of patients. 13 , 15 Migration has been reported in the thorax, abdomen, and pelvic region, with the thorax being the most common site, reportedly in 18%–55% of patients. 16 , 17 Seed migration into the body is often asymptomatic, thus it is less frequently reported, and clinical dosimetry effects have not been reported. 16 , 18 , 19
Conclusion
We report a case with seed migration into the bladder after LDR‐B for prostate cancer. Seeds should be carefully located within the prostate, otherwise seeds may migrate into the bladder and form a bladder stone encompassing the seed. A close examination should be performed if symptoms, such as dysuria and hematuria appeared.
Approval of the research protocol by an Institutional Review Board
Not applicable.
Author contributions
Shuhei Aoyama: Data curation; investigation; project administration; resources; visualization; writing – original draft; writing – review and editing. Kouji Izumi: Conceptualization; project administration; resources; writing – review and editing. Suguru Kadomoto: Writing – review and editing. Tomoyuki Makino: Writing – review and editing. Renato Naito: Writing – review and editing. Hiroaki Iwamoto: Writing – review and editing. Hiroshi Yaegashi: Writing – review and editing. Shohei Kawaguchi: Writing – review and editing. Kazuyoshi Shigehara: Writing – review and editing. Takahiro Nohara: Writing – review and editing. Atsushi Mizokami: Supervision; writing – review and editing.
Conflict of interest
The authors declare no conflict of interest.
Informed consent
Not applicable.
Registry and the Registration No. of the study/trial
Not applicable.
Data accessibility
Not applicable.
References
- 1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians 2021; 71: 209–249. [DOI] [PubMed] [Google Scholar]
- 2. Potters L, Klein EA, Kattan MW et al. Monotherapy for stage T1–T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiotherapy and Oncology 2004; 71: 29–33. [DOI] [PubMed] [Google Scholar]
- 3. Blumenthal KB, Sutherland DE, Wagner KR, Frazier HA, Engel JD. Bladder neck contractures related to the use of hem‐o‐lok clips in robot‐assisted laparoscopic radical prostatectomy. Urology 2008; 72: 158–161. [DOI] [PubMed] [Google Scholar]
- 4. Turini GA III, Brito JM III, Leone AR et al. Intravesical hemostatic clip migration after robotic prostatectomy: case series and review of the literature. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A 2016; 26: 710–712. [DOI] [PubMed] [Google Scholar]
- 5. Iemura Y, Kagebayashi Y, Fukui S, Matsumura Y, Tatsumi Y, Samma S. Migration of hem‐o‐Lok clips into the urinary bladder used during robot‐assisted laparoscopic prostatectomy. Hinyokika Kiyo 2019; 65: 65–68. [DOI] [PubMed] [Google Scholar]
- 6. Ohyama T, Shimbo M, Endo F, Hattori K. Late‐onset hem‐o‐Lok® migration into the bladder after robot‐assisted radical prostatectomy. IJU Case Reports 2021; 5: 49–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Chen CT, Tang C, Hsieh TS. Migration of the prostate brachytherapy seeds into urinary bladder with stone formation: a case report. Asian Journal of Surgery 2021; 44: 1131–1132. [DOI] [PubMed] [Google Scholar]
- 8. Haroun RR, Nance JW Jr, Fishman EK. Prostate brachytherapy seed migration to the bladder presenting with gross hematuria. J. Radiol. Case Rep. 2016; 10: 22–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kamisawa K, Kosaka T, Hongo H, Mizuno R, Oya M. Brachytherapy seeds as a nidus for urethral stone formation: a case report. IJU Case Reports 2019; 2: 206–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Frank SJ, Pugh TJ, Blanchard P et al. Prospective phase 2 trial of permanent seed implantation prostate brachytherapy for intermediate‐risk localized prostate cancer: efficacy, toxicity, and quality of life outcomes. International Journal of Radiation Oncology, Biology, Physics 2018; 100: 374–382. [DOI] [PubMed] [Google Scholar]
- 11. Gómez‐Iturriaga Piña A, Crook J, Borg J, Ma C. Biochemical disease‐free rate and toxicity for men treated with iodine‐125 prostate brachytherapy with d(90) ≥180 Gy. International Journal of Radiation Oncology, Biology, Physics 2010; 78: 422–427. [DOI] [PubMed] [Google Scholar]
- 12. Chao M, Spencer S, Guerrieri M et al. A single institution analysis of low‐dose‐rate brachytherapy: 5‐year reported survival and late toxicity outcomes. J. Contemp. Brachyther. 2018; 10: 155–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Helou J, Charas T. Acute and late side‐effects after low dose‐rate brachytherapy for prostate cancer; incidence, management and technical considerations. Brachytherapy 2021; 20: 956–965. [DOI] [PubMed] [Google Scholar]
- 14. Toriumi R, Yaegashi H, Sakurai T et al. Ischemic proctitis after low‐dose‐rate brachytherapy using hydrogel spacer for prostate cancer. IJU Case Reports 2022; 5: 237–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Nguyen BD, Schild SE, Wong WW, Vora SA. Prostate brachytherapy seed embolization to the right renal artery. Brachytherapy 2009; 8: 309–312. [DOI] [PubMed] [Google Scholar]
- 16. Eshleman JS, Davis BJ, Pisansky TM et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. International Journal of Radiation Oncology, Biology, Physics 2004; 59: 419–425. [DOI] [PubMed] [Google Scholar]
- 17. Taussky D, Moumdjian C, Larouche R et al. Seed migration in prostate brachytherapy depends on experience and technique. Brachytherapy 2012; 11: 452–456. [DOI] [PubMed] [Google Scholar]
- 18. Maletzki P, Schwab C, Markart P et al. Late seed migration after prostate brachytherapy with Iod‐125 permanent implants. Prostate International 2018; 6: 66–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Yorozu A, Toya K, Ohashi T, Monma T, Saito S. Seed loss through the urinary tract and retrieval after prostate seed implant. Nihon Igaku Hoshasen Gakkai Zasshi 2005; 65: 263–265. [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.
